Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

4 Stocks Climbing To The Top: CLDX, IPXL, MBLY, SUNE

Published 03/12/2015, 01:20 AM
Updated 07/09/2023, 06:31 AM

The stock market is still in a weak mode, but based on the technicals from Wednesday, which were not from the downside, and not pressing the oscillators much lower, that we may be on the throes of a snapback move. We just don’t have a feel for where the bottom is yet. I will say, the market completed 5-waves. A lot of individual stocks are still acting well. Let’s take a look at some of them.

Celldex Therapeutics, (NASDAQ:CLDX), with a nice little pop off the 3-day pullback, was up 1.04 to 29.45, or 3.6%, on 21 million shares on Wednesday. The volume increased a little bit, the best in four days. Let’s see if it will get some extension on this. There’s resistance at 31, the target is at 34ish, and then 39. With this kind of pattern, a lot can happen. Stay tuned.

Impax Laboratories (NASDAQ:IPXL) was up 3.77 to 42.23, or 9.8%, on 12.6 million shares on Wednesday. It popped across the February highs to all-time highs. The long-term channel calls for a move up to 45.

MOBILEYE N.V. (NYSE:MBLY) is doing great. The swing trade is working, and for 7 days this stock has been up, including the breakaway move over the moving averages, and on Tuesday, it moved over the declining topsline and lateral price resistance as well as the 50-day moving averages. On Wednesday, it was up 1.22 to 40.10, or 3%, on 5.7 million shares. I’m looking for a test of the 42.40 area, followed by the 46 1/4-1/2 area.

SunEdison, (NYSE:SUNE) popped 1.03 to 23.20, or 4.65%, on 11.7 million shares on Wednesday. Good volume. It’s up against resistance, and is trying to break out. It’s at a very, very key level. If it gets though this, you’ll see dramatic movement, perhaps as high as 28-29.

Other stocks on Harry’s Charts of the Day included Advaxis, (NASDAQ:ADXS), Agenus (NASDAQ:AGEN), Ampio Pharmaceuticals, (AMEX:AMPE), Capnia, (NASDAQ:CAPN), Covenant Transportation (NASDAQ:CVTI), Amicus Therapeutics, (NASDAQ:FOLD), Globalstar (AMEX:GSAT), Horizon Pharma,(NASDAQ:HZNP), iBio, (AMEX:IBIO), Ocular Therapeutix, (NASDAQ:OCUL), Supernus Pharmaceuticals, (NASDAQ:SUPN), and Solazyme (NASDAQ:SZYM).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.